#nieuws

Breaking
biotech
news!

Het meest relevante nieuws uit de medische, agri-food en industriële biotech sector.

Op naar de arm (deel II): kabinet publiceert Nederlandse COVID-vaccinatiestrategie

24 november 2020

CureVac and WACKER Sign Manufacturing Contract forCureVac’s COVID-19 Vaccine Candidate:CVnCoV

23 november 2020

Alnylam Receives Approval for OXLUMO™ (lumasiran) in the European Union for the Treatment of Primary Hyperoxaluria Type 1 in All Age Groups

23 november 2020

European Commission approves Supemtek® (quadrivalent recombinant influenza vaccine) for the prevention of influenza in adults aged 18 years and older

23 november 2020

AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19

23 november 2020

Mymetics to advance Preclinical Studies for Virosome-based Covid-19 Vaccine through Innosuisse grant

23 november 2020

Pharvaris Announces $80 Million Series C Financing to Advance Novel Oral Bradykinin-B2-Receptor Antagonists for the Treatment of HAE

23 november 2020

Pharming gaat nieuwe downstream-productiefaciliteit voor RUCONEST® bouwen op Pivot Park in Oss

23 november 2020

Immunicum AB and DCprime Combine Forces to Establish Leader in Cell-Based Cancer Immunotherapies

23 november 2020

Catalyze to receive FD Gazelle 2020 award

23 november 2020

Op naar de arm: waar blijft dat nationale corona-vaccinatieplan?

17 november 2020

Crisp & malty. Your first CRISPR beer

17 november 2020

Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study

17 november 2020

Bouwen aan een Europese gezondheidsunie: betere crisisparaatheid en -respons voor Europa

17 november 2020

Nieuwe corona-behandeling met bloedplasma kan starten

17 november 2020

AM-Pharma Announces Enrollment of the First Patient in REVIVAL Phase III Pivotal Trial in Patients with Sepsis-Associated Acute Kidney Injury

17 november 2020

Lead Pharma uit Oss sluit deal voor €260 miljoen met Roche

17 november 2020

New fund to impact tomorrow’s healthcare: launch of Thuja Capital Healthcare Fund III

17 november 2020